Stock Movers: AstraZeneca, Glencore, Argenx in Market Shakes
Analyze the market movements of AstraZeneca, Glencore, and Argenx as they face different challenges and opportunities. Dive into the reasons behind AstraZeneca's clinical trial halt, Glencore's copper supply deal, and Argenx's positive drug trial results.📥 Connect with The Market EdgeEnjoyed this episode? Make sure to follow the channel and turn on notifications so you never miss a market breakdown.Spreaker: The Market Edge LinkBusiness Inquiries: golden.wave.soundworks@gmail.com📈 About The Market EdgeThe Market Edge strips away the hype to deliver sharp, data-driven insights, macroeconomic…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.